Vericel Corp Ord Stock Performance
| VCEL Stock | USD 46.42 1.04 2.29% |
Vericel Corp has a performance score of 5 on a scale of 0 to 100. The entity has a beta of 1.85, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vericel Corp will likely underperform. Vericel Corp Ord right now has a risk of 2.18%. Please validate Vericel Corp skewness, and the relationship between the potential upside and rate of daily change , to decide if Vericel Corp will be following its existing price patterns.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Vericel Corp may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
Actual Historical Performance (%)
One Day Return (0.24) | Five Day Return 6.05 | Year To Date Return 32.77 | Ten Year Return 979.49 | All Time Return (95.87) |
Last Split Factor 1:20 | Last Split Date 2013-10-16 |
1 | Acquisition by Jonathan Hopper of 1750 shares of Vericel Corp subject to Rule 16b-3 | 02/20/2024 |
2 | Vericel Given New 53.00 Price Target at HC Wainwright | 03/01/2024 |
3 | Vericel Co. to Post Q3 2024 Earnings of Per Share, Leerink Partnrs Forecasts | 03/06/2024 |
4 | Disposition of 1634 shares by Jonathan Siegal of Vericel Corp at 45.0 subject to Rule 16b-3 | 03/07/2024 |
5 | Baker Avenue Asset Management LP Takes 1.30 Million Position in Vericel Co. | 03/08/2024 |
6 | Disposition of 7874 shares by Michael Halpin of Vericel Corp at 44.71 subject to Rule 16b-3 | 03/11/2024 |
7 | Insider Sell COO Michael Halpin Sells 7,874 Shares of Vericel Corp | 03/13/2024 |
8 | Disposition of 17500 shares by Dominick Colangelo of Vericel Corp at 44.02 subject to Rule 16b-3 | 03/14/2024 |
9 | Disposition of 17500 shares by Dominick Colangelo of Vericel Corp at 44.67 subject to Rule 16b-3 | 03/18/2024 |
10 | MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update | 03/21/2024 |
11 | Acquisition by Robert Zerbe of 3278 shares of Vericel Corp at 3.74 subject to Rule 16b-3 | 03/27/2024 |
12 | Global Regenerative Medicine Market to Touch Valuation of USD 472.95 Billion by 2032, at 25.86 percent CAGR Astute Analytica | 04/01/2024 |
13 | Investors might be losing patience for Vericels increasing losses, as stock sheds 3.5 percent over the past week | 04/08/2024 |
14 | Acquisition by Alan Rubino of 3000 shares of Vericel Corp at 4.12 subject to Rule 16b-3 | 04/09/2024 |
15 | Disposition of 17500 shares by Dominick Colangelo of Vericel Corp at 46.47 subject to Rule 16b-3 | 04/17/2024 |
16 | Disposition of 17500 shares by Dominick Colangelo of Vericel Corp at 44.59 subject to Rule 16b-3 | 04/18/2024 |
17 | Vericel CEO sells over 1.5m in company stock | 04/19/2024 |
| Begin Period Cash Flow | 51.1 M |
Vericel |
Vericel Corp Relative Risk vs. Return Landscape
If you would invest 4,260 in Vericel Corp Ord on January 25, 2024 and sell it today you would earn a total of 382.00 from holding Vericel Corp Ord or generate 8.97% return on investment over 90 days. Vericel Corp Ord is currently generating 0.1598% in daily expected returns and assumes 2.1833% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than Vericel, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vericel Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vericel Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vericel Corp Ord, and traders can use it to determine the average amount a Vericel Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0732
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VCEL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.18 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Vericel Corp is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vericel Corp by adding it to a well-diversified portfolio.
Vericel Corp Fundamentals Growth
Vericel Stock prices reflect investors' perceptions of the future prospects and financial health of Vericel Corp, and Vericel Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vericel Stock performance.
| Return On Equity | -0.0152 | ||||
| Return On Asset | -0.0129 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 2.22 B | ||||
| Shares Outstanding | 48.38 M | ||||
| Price To Earning | 357.33 X | ||||
| Price To Book | 10.26 X | ||||
| Price To Sales | 11.73 X | ||||
| Revenue | 197.52 M | ||||
| Gross Profit | 109.79 M | ||||
| EBITDA | (1.83 M) | ||||
| Net Income | (3.18 M) | ||||
| Cash And Equivalents | 100.69 M | ||||
| Cash Per Share | 2.13 X | ||||
| Total Debt | 88.14 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 4.72 X | ||||
| Cash Flow From Operations | 35.31 M | ||||
| Earnings Per Share | (0.07) X | ||||
| Market Capitalization | 2.25 B | ||||
| Total Asset | 353.66 M | ||||
| Retained Earnings | (403.18 M) | ||||
| Working Capital | 159.88 M | ||||
| Current Asset | 21.1 M | ||||
| Current Liabilities | 15.36 M | ||||
About Vericel Corp Performance
To evaluate Vericel Corp Ord Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Vericel Corp generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Vericel Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Vericel Corp Ord market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Vericel's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 77.12 | 73.26 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Vericel Corp Ord performance evaluation
Checking the ongoing alerts about Vericel Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vericel Corp Ord help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 197.52 M. Net Loss for the year was (3.18 M) with profit before overhead, payroll, taxes, and interest of 109.79 M. | |
| Over 99.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investing.com: Vericel CEO sells over 1.5m in company stock |
- Analyzing Vericel Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vericel Corp's stock is overvalued or undervalued compared to its peers.
- Examining Vericel Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vericel Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vericel Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vericel Corp's stock. These opinions can provide insight into Vericel Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Vericel Stock analysis
When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share (0.07) | Revenue Per Share 4.15 | Quarterly Revenue Growth 0.233 | Return On Assets (0.01) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.